1. Home
  2. GHG vs NKTR Comparison

GHG vs NKTR Comparison

Compare GHG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.03

Market Cap

116.0M

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$68.68

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
NKTR
Founded
2004
1990
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
2.2B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
GHG
NKTR
Price
$1.03
$68.68
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$146.67
AVG Volume (30 Days)
8.9K
499.1K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
86.00
52 Week Low
$0.99
$33.40
52 Week High
$2.31
$109.00

Technical Indicators

Market Signals
Indicator
GHG
NKTR
Relative Strength Index (RSI) 27.08 40.94
Support Level N/A $64.28
Resistance Level $1.12 $76.49
Average True Range (ATR) 0.04 2.67
MACD -0.01 -0.61
Stochastic Oscillator 11.76 13.29

Price Performance

Historical Comparison
GHG
NKTR

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: